Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

FDA awards QIDP designation to Ixogel for prevention of Lyme disease

Oct. 1, 2015

Novel 2-pyridone antibacterials to treat Gram-negative bacterial infections

Oct. 1, 2015

SEQ-9, a novel macrolide for the treatment of tuberculosis

Oct. 1, 2015

BiondVax begins phase IIb trial of universal flu vaccine in Europe

Oct. 1, 2015

Polyphor/Roche macrocyclic peptide to combat multidrug-resistant bacterial infections

Oct. 1, 2015

Maruho's Zebiax approved in Japan for bacterial skin infections

Sep. 30, 2015

Department of Health of the U.K. and JNCASR describe antimicrobial conjugates

Sep. 30, 2015

IURTC and Assembly Biosciences patent HBV core protein allosteric modulators

Sep. 30, 2015

F2G reports PK/PD profile of novel orotomide antifungal F-901318

Sep. 30, 2015

Fungal CYP51 inhibitors to overcome resistance

Sep. 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...